Overall population | Males (N = 680) | Females (N = 787) | |
---|---|---|---|
Age (years, mean ± SD) | 72.1 (± 7.8) | 71.7 (± 7.6) | 72.4 (± 8.0) |
BMI (kg/m2, mean ± SD) | 25.5 (± 3.8) | 26.1 (± 3.5) | 24.9 (± 4.0) |
CRP (mg/l, mean ± SD) | 2.7 (± 6.0) | 2.8 (± 5.7) | 2.6 (± 6.3) |
Crea (mg/dl, mean ± SD) | 77.0 (± 19.5) | 87.0 (± 18.8) | 68.3(± 15.6) |
CysC (mg/l, mean ± SD) | 0.8 (± 0.2) | 0.9 (± 0.2) | 0.8 (± 0.2) |
Albumin (g/l, mean ± SD) | 43.2 (± 2.6) | 43.2 (± 2.7) | 43.2 (± 2.5) |
HOMA-IR (mean ± SD) | 2.5 (± 6.5) | 3.1 (± 9.5) | 2.1 (± 1.6) |
Hb1Ac (%, mean ± SD) | 5.9 (± 0.6) | 5.9 (± 0.7) | 5.9 (± 0.5) |
25-OH vitamin D (mmol/l) | 23.9 (± 11.0) | 23.2 (± 10.4) | 24.6(± 11.3) |
Diabetes, n (%) | |||
Yes | 70 (4.8%) | 52 (7.7%) | 18 (2.2%) |
No | 1397 (95.2%) | 628 (92.3%) | 769 (97.8%) |
Hypertension, n (%) | |||
Yes | 562 (38.3%) | 285 (41.9%) | 277 (35.2%) |
No | 905 (61.7%) | 395 (58.1%) | 510 (64.8%) |
Renal disease, n (%) | |||
Yes | 36 (2.5%) | 18 (2.6%) | 18 (2.3%) |
No | 1431 (97.5%) | 662 (97.4%) | 769 (97.7%) |
History of neoplasia, n (%) | |||
Yes | 106 (7.2%) | 48 (7.1%) | 58 (7.4%) |
No | 1361 (92.8%) | 632 (92.9%) | 729 (92.6%) |
Pulmonary disease, n (%) | |||
Yes | 22 (1.5%) | 10 (1.5%) | 12 (1.5%) |
No | 1445 (98.5%) | 670 (98.5%) | 775 (98.5%) |
Neurological disorders, n (%) | |||
Yes | 263 (17.9%) | 127 (18.7%) | 136 (17.3%) |
No | 1204 (82.1%) | 553 (81.3%) | 651 (82.7%) |
Smoking (active), n (%) | |||
Yes | 100 (6.8%) | 63 (9.3%) | 37 (4.7%) |
No | 1367 (93.2%) | 617 (90.7%) | 750 (95.3%) |
Rheumatologic disorders, n (%) | |||
Yes | 154 (10.5%) | 56 (8.2%) | 98 (12.5%) |
No | 1313 (89.5%) | 624 (91.8) | 689 (87.5%) |
Bleeding disorders, n (%) | |||
Yes | 14 (0.9%) | 8 (1.2%) | 6 (0.8%) |
No | 1453 (99.1%) | 672 (98.8%) | 781 (99.2%) |
Osteoporosis, n (%) | |||
Yes | 53 (3.6%) | 3 (0.4%) | 50 (6.3%) |
No | 1414 (96.4%) | 677 (99.6%) | 737 (93.7%) |
Depression syndrome, n (%) | |||
Yes | 30 (2.0%) | 4 (0.6%) | 26 (3.3%) |
No | 1437 (98.0%) | 676 (99.4%) | 761 (96.7%) |
Medications, n (%) | |||
≤ 2 | 1170 (79.7%) | 512 (75.3%) | 658 (83.6%) |
3–5 | 293 (20.0%) | 165 (24.3%) | 128 (16.3%) |
≥ 6 | 4 (0.3%) | 3 (0.4%) | 1 (0.1%) |